A- A A+

UNODC. UNODC New Psychoactive Substances Portal and International Collaborative Exercise Portal

Welcome to the online portals of the UNODC Laboratory and Scientific Service. From this page you can access both portals. Please click on the icons below to be redirected to the portal of your choice. (Registrierung erforderlich, 19.05.2023)


UNODC. NPS Data Visualisations

We are pleased to announce a new, interactive feature of the UNODC Early Warning Advisory (EWA) - the Summary Dashboard - that allows to quickly explore and visualize the new psychoactive substances (NPS) data available in the UNODC EWA. (UNODC, Wien, Februar 2023)


Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances. 

Di Trana A, Berardinelli D, Montanari E, Berretta P, Basile G, Huestis MA, Busardò FP. 

Int J Mol Sci. 2022 Nov 23;23(23):14619. doi: 10.3390/ijms232314619. PMID: 36498947; PMCID: PMC9739917.


What you need to know about 3‑MMC, the party drug of the moment 

Last year, the drug was found in a load of the UK’s pill supply. Now, 3-MMC has been doing the rounds in the Berlin party scene. But what actually is it? (The Face, UK, 07.10.2022)


‘Canberra ketamine’: new recreational drug discovered at Australian pill-testing service

‘As far as we’re aware, this is the first detection of a new drug by a drug-checking service anywhere in the world,’ says professor. (The Guardian, UK, 18.10.2022)


NPS Discovery Toolkit: N-Pyrrolidino Etonitazene

NPS Discovery (2022), Center for Forensic Science Research and Education,

United States of America.


EMCDDA. Brochure: 25 years of monitoring and responding to new drugs in Europe


This brochure provides an overview of 25 years of the EU Early Warning System (EWS) on new psychoactive substances (NPS). Operated by the EMCDDA in close cooperation with Europol and other partners, it was the first regional early warning mechanism set up to monitor and respond to uncontrolled new drugs. The system ensures that the EU and its Member States have up-to-the-minute information on NPS and the threats they pose to Europe, in order to protect public health and inform decision-making. (Lissabon, Oktober 2022)


A review of synthetic cathinones emerging in recent years (2019-2022). 

Kuropka P, Zawadzki M, Szpot P. 

Forensic Toxicol. 2022 Sep 15:1-22. doi: 10.1007/s11419-022-00639-5. Epub ahead of print. PMID: 36124107; PMCID: PMC9476408.


UNODC. Current NPS Threats, Volume V

Over 1150 NPS from 137 countries and territories have been reported to the UNODC Early Warning Advisory on New Psychoactive Substances

- Benzodiazepine-type substances continue to be a primary NPS threat,
reported in 47% of post-mortem and 67% of drug driving cases

- Synthetic opioid NPS are the second highest group of NPS reported inboth post-mortem and drug driving cases. (UNODC, Wien, October 2022)


Legal Reponses to Novel Psychoactive Substances implemented by ten European Countries: an analysis from legal epidemiology

Jessica Neicun, Andres Roman-Urrestarazu, Katarzyna Czabanowska

Emerging Trends in Drugs, Addictions, and Health, Available online 5 August 2022, 100044, doi.org/10.1016/j.etdah.2022.100044


Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures. 

Barenholtz E, Krotulski AJ, Morris P, Fitzgerald ND, Le A, Papsun DM, Logan BK, Hahn WE, Goldberger BA, Cottler LB, Palamar JJ. 

Int J Drug Policy. 2021 Dec;98:103393. doi: 10.1016/j.drugpo.2021.103393. Epub 2021 Aug 5. PMID: 34365124; PMCID: PMC8671170.


USA. Q2 2022 Trend Reports: NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids

About: With funding from the National Institute of Justice (NIJ), the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation is developing quarterly trend reports in relation to novel psychoactive substance (NPS) use in the United States, with a focus on four main classifications: benzodiazepines, opioids, stimulants and hallucinogens, and synthetic cannabinoids. The goal of this specific initiative is to provide near real-time information regarding NPS prevalence and positivity based on the analysis of authentic forensic casework samples. (Center for Forensic Science Research and Education (CFSRE), USA, Juli 2022)


EMCDDA. New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning System

This update from the EU Early Warning System overviews the NPS situation in Europe in 2020-2021 and highlights emerging threats to support early warning, preparedness planning and response measures. In addition, it reflects on the changes and the lessons learned from 25 years of monitoring NPS in Europe. (EMCDDA, Lissabon, Juni 2022)


New Psychoactive Substances Consumption in Opioid-Use Disorder Patients. 

Alías-Ferri M, Pellegrini M, Marchei E, Pacifici R, Rotolo MC, Pichini S, Pérez-Mañá C, Papaseit E, Muga R, Fonseca F, Torrens M, Farré M. 

Biology (Basel). 2022 Apr 22;11(5):645. doi: 10.3390/biology11050645. PMID: 35625373; PMCID: PMC9138226.


Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse. 

Correia B, Fernandes J, Botica MJ, Ferreira C, Quintas A. 

Medicines (Basel). 2022 Mar 1;9(3):19. doi: 10.3390/medicines9030019. PMID: 35323718; PMCID: PMC8950629.


Novel psychoactive substance. 

Pucci M, Bradberry S, Ford L. 

Clin Med (Lond). 2021 Jul;21(4):e430-e431. doi: 10.7861/clinmed.Let.21.4.9. PMID: 35192500; PMCID: PMC8313199.


A deep generative model enables automated structure elucidation of novel psychoactive substances. 

Skinnider, M.A., Wang, F., Pasin, D. et al.

Nat Mach Intell 3, 973–984 (2021). doi.org/10.1038/s42256-021-00407-x


UNODC. Current NPS Threats - Volume IV - November 2021

Over 1100 NPS from 133 countries and territories have been reported to the UNODC Early Warning Advisory on New Psychoactive Substances

Benzodiazepine-type substances are a primary NPS threat, identified in 68% of toxicology cases

Poly-drug use continues to be a major feature of toxicology reports, particularly in cases concerning fatalities and driving under the influence of drugs. (UNODC, Wien, November 2021)



UNODC. Synthetic Drugs and New Psychoactive Substances in Latin America and the Caribbean - 2021

The report provides a regional analysis of the key trends and emerging developments of the synthetic drugs and NPS market as well as options for response in Latin America and the Caribbean. Over the past years, the synthetics drug market has experienced a massive expansion and diversification in the region and seen a rapid emergence of a wide range of NPS. The latest developments include an expanding methamphetamine market, growing concerns around the non-medical use of ketamine, the emergence of fentanyl and MDMA manufacture, as well as new “ecstasy” trends such as higher dosed MDMA tablets and new forms of presentation such as crystalline MDMA. Moreover, the report sheds light on the comparatively high prevalence of use of hallucinogens in the region and the high prevalence of use of tranquilizers among women. (UNODC, Wien, September 2021)


USA. NPS Discovery: Welcome to our premier open-access drug early warning system! 

Our evidence-based approach leads the development of high impact reports for real-time action.

ABOUT US: The Center for Forensic Science Research and Education (CFSRE) is working in collaboration with law enforcement, public health, and public safety agencies to rapidly identify emerging drugs, also known as Novel Psychoactive Substances (NPS), associated with intoxications and adverse events. The information, reports, and resources consolidated here by the CFSRE allow for the rapid dissemination of information to stakeholders and affected communities. (NPS Discovery, USA, 2021)


USA. Recommended Scope for NPS Testing in the United States

Purpose: The objective of this report is to provide updated guidance in developing an appropriate analytical scope of testing for novel psychoactive substances (NPS) in the United States based on current trends and intelligence. This report is based on information available in Q3 2021 and is subject to change along with the drug market. (NPS Discovery, USA, Oktober 2021)


Eurasien. NPS use in Eastern Europe and Central Asia

Throughout the Eastern Europe and Central Asia (EECA) region, the use and variety of NPS are relevant issues, although the nature and extent differ among the EECA countries and subregions, with better awareness of their presence among health professionals and people who use drugs. Synthetic cannabinoids and synthetic cathinones are predominant groups of NPS and widely available, whereas synthetic opioids seem to be more present in Estonia and Lithuania. Among people who use NPS, there are two key populations: those who have more experience with use of drugs, who have shifted to the use of NPS for a variety of reasons, and young people with no previous history of drug use. (Eurasian Harm Reduction Association (EHRA), 2021)


Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports. 

Ordak M, Zmysłowska A, Bielski M, Rybak D, Tomaszewska M, Wyszomierska K, Kmiec A, Garlicka N, Zalewska M, Zalewski M, Nasierowski T, Muszynska E, Bujalska-Zadrozny M. 

Front Psychiatry. 2021 Apr 23;12:669921. doi: 10.3389/fpsyt.2021.669921. PMID: 33967865; PMCID: PMC8102790.


Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital. 

Tanti M, Cosgrove J, Kelleher C, Jones R, Maguire M. 

Clin Med (Lond). 2021 May;21(3):189-194. doi: 10.7861/clinmed.2020-0706. Epub 2021 May 4. PMID: 33947659; PMCID: PMC8140705.


Patterns of new psychoactive substance use among opioid-dependent patients attending for opioid substitution treatment

McCarron P., Smyth B., Carroll G., Glynn M., Barry J., Whiston L., Keenan E., Darker C., and Truszkowska E.

Heroin Addiction and Related Clinical Problems, Published Ahead of Print, May 3, 2021


International Perspective on New Psychoactive Substances (NPS) – Virtual seminar 18 June 08.00-09.15 (Berlin time)

This seminar is offered within the context of SOLID project funded by DAAD (German Academic Exchange Service Exceed program) and implemented at the Frankfurt University of Applied Sciences and across five Universities in Central Asia (Kazakhstan, Kyrgyzstan, Uzbekistan) and China (Shanghai). Our partners informed us about a significant structural change in the drug use consumption patterns in their countries. The experts are reporting a continuous decrease of the trafficking and consumption of opioids, such as opium and heroin, whereas the trafficking and consumption of New Psychoactive Substances (NPS) (Central Asia) and methamphetamines (China) especially via internet/darknet is increasing. They are also reporting that the services to reduce the drug related harms and treatment centres have not enough knowledge and tools to deal with patients suffering from overdoses and health problems due to the consumption of NPS/Methamphetamines.


Hot” and “Cold” Cognition in Users of Club Drugs/Novel Psychoactive Substances  

Savulich George, Bowden-Jones Owen, Stephenson Robert, Brühl Annette B., Ersche Karen D., Robbins Trevor W., Sahakian Barbara J.

Frontiers in Psychiatry, VOLUME 12, 2021, p333, DOI=10.3389/fpsyt.2021.660575


"Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs" 

Lukić, Vera, Micić, Ružica, Arsić, Biljana, Nedović, Bojan and Radosavljević, Živana. 

Open Chemistry, vol. 19, no. 1, 2021, pp. 60-106. doi.org/10.1515/chem-2021-0196


New psychoactive substances: a review and updates. 

Shafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. 

Ther Adv Psychopharmacol. 2020 Dec 17;10:2045125320967197. doi: 10.1177/2045125320967197. PMID: 33414905; PMCID: PMC7750892.


January 2021 – UNODC-SMART: Almost 1,050 NPS reported to UNODC from 126 countries and territories

VIENNA, Austria – January 2021: New psychoactive substances (NPS) remain a global phenomenon with 126 countries and territories from all regions of the world having reported one or more NPS to the UNODC Early Warning Advisory (EWA) on NPS. Governments, forensic laboratories and partner organisations worldwide have identified and reported a total of 1,047 substances up to December 2020 to the UNODC EWA on NPS. (UNODC Laboratory and Scientific Section, Januar 2021)